Scisparc Stock Investor Sentiment

SPRC Stock  USD 0.21  0.01  4.55%   
About 61% of Scisparc's investor base is looking to short. The analysis of the overall investor sentiment regarding Scisparc suggests that many traders are alarmed. The current market sentiment, together with Scisparc's historical and current headlines, can help investors time the market. In addition, many technical investors use Scisparc stock news signals to limit their universe of possible portfolio assets.
  

Scisparc Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Scisparc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over two months ago at seekingalpha.com         
SciSparc extends additional loan of 1.85M to AutoMax
seekingalpha News
over two months ago at globenewswire.com         
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application f...
Macroaxis News: globenewswire.com
over three months ago at globenewswire.com         
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamin...
Macroaxis News: globenewswire.com
over three months ago at globenewswire.com         
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to 6 Million
Macroaxis News: globenewswire.com
over three months ago at seekingalpha.com         
SciSparc files to sell 21M ordinary shares for holders
seekingalpha News
over three months ago at finance.yahoo.com         
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to 6 Million
Yahoo News
over three months ago at finance.yahoo.com         
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with...
Yahoo News
over three months ago at finance.yahoo.com         
SciSparc MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Bo...
Yahoo News
over three months ago at globenewswire.com         
SciSparc MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Bo...
Macroaxis News: globenewswire.com
over three months ago at news.google.com         
SciSparc Trading Up 13.5 percent - Defense World
Google News at Macroaxis
over three months ago at benzinga.com         
Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy
benzinga news
over three months ago at globenewswire.com         
SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI...
Macroaxis News: globenewswire.com
over three months ago at finance.yahoo.com         
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at 3 million
Yahoo News
over three months ago at seekingalpha.com         
SciSparc licenses SCI-160 pain drug program to Polyrizon
seekingalpha News
over three months ago at globenewswire.com         
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at 3 million
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Scisparc that are available to investors today. That information is available publicly through Scisparc media outlets and privately through word of mouth or via Scisparc internal channels. However, regardless of the origin, that massive amount of Scisparc data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Scisparc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Scisparc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Scisparc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Scisparc alpha.

Scisparc Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
SciSparc extends additional loan of 1.85M to AutoMax
09/11/2024
2
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy
09/16/2024
3
SciSparc signs LOI to sell entire ownership in MitoCareX
09/26/2024
4
National Poll on Perceptions of Mental Health and Suicide Prevention Reveals Most U.S. Adults Believe Suicide is Preventable
10/09/2024
5
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
11/04/2024

Complementary Tools for Scisparc Stock analysis

When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing